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ORIGINAL ARTICLE
Factors associated with increase in blood pressure and incident
hypertension in early midlife: the Hordaland Health Study
Ester Kringelanda, Grethe S. Tellb,c, Helga Midtbød, Teresa R. Haugsgjerdb, Jannicke Iglandb and
Eva Gerdtsa,d
aDepartment of Clinical Science, University of Bergen, Bergen, Norway; bDepartment of Global Public Health and Primary Care,
University of Bergen, Bergen, Norway; cDivision of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway;
dDepartment of Heart Disease, Haukeland University Hospital, Bergen, Norway
ABSTRACT
Purpose: We aimed to identify sex-specific factors associated with increase in blood pressure
(BP) and incident hypertension in early midlife.
Materials and methods: 2,008 women and 1,610 men aged 40-43 years were followed for six
years in the Hordaland Health Study. Participants taking antihypertensive medication at baseline
were excluded. High-normal BP was defined as baseline BP 130-139/85-89 mmHg, and incident
hypertension as BP140/90 mmHg or use of antihypertensive medication at follow-up.
Results: During follow-up, an increase in systolic (SBP) and diastolic (DBP) BP was observed in
54% and 30% of women vs. 44% and 41% of men, respectively (both p<0.001). In both sexes
higher baseline body mass index (BMI) and increases in BMI and serum lipids were associated
with increases in SBP and DBP during follow-up (all p<0.05). Incident hypertension was more
common in men (14 vs.11%, p<0.01), and predicted by higher BMI and high-normal BP at base-
line in both sexes, and by higher serum triglyceride level in women (all p<0.01).
Conclusion: In the Hordaland Health Study, BP development differed between women and men
in early midlife. The main factors associated with BP increase in both sexes were higher BMI,
weight gain and increases in serum lipids.
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Introduction
The World Health Organization has defined hyper-
tension as the leading risk factor for cardiovascular
(CV) disease (CVD), and currently, 1 in 4 men and 1
in 5 women have hypertension worldwide [1]. The
global obesity epidemic has been identified as a major
driver for the increasing incidence and prevalence of
hypertension [2,3]. As demonstrated both in the
Framingham Study and the Strong Heart Study, the
main risk factors for incident hypertension in 50-
year-old subjects were obesity and diabetes [2,3].
However, sex-specific results were not presented. In
contrast, in the Tromsø Study, high body mass index
(BMI) was a more important predictor of blood pres-
sure (BP) increase in women than in men [4].
Although the prevalence of hypertension rises with
increasing age in both sexes, there is a striking differ-
ence in BP changes between women and men [5,6].
While the rate of increase in BP attenuates in men after
40years, the rates of increase in both systolic BP (SBP)
and diastolic BP (DBP) remain constant with ageing in
women [6]. As a consequence, hypertension is more
common in men than in women before the age of
40 years, while after the age of 60 years more women
have hypertension [5,7]. Even in the very elderly above
90 years of age, a larger proportion of women than
men have hypertension [8]. Thus, there is a need for
further sex-specific knowledge on factors associated
with BP increase and incident hypertension, in particu-
lar in early midlife. The aim of the current study was
to identify sex-specific factors associated with increases
in SBP, DBP and incident hypertension in women and
men in their forties, using data from the community-
based Hordaland Health study in Western Norway.
Methods
Study population
The Hordaland Health study is a community-based
study in Hordaland County in Western Norway,
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initiated as a collaboration between the National
Health Screening Service, the University of Bergen
and local health services in 1992 (https://husk-en.w.
uib.no/) [9,10]. Eligible subjects were identified from
the National Population Registry based on year of
birth and site of residence. The current study focused
on the 2050 women and 1650 men, born 1950–1951
who had participated at both the 1992–1993 (baseline)
and 1997–1999 (follow-up) surveys [9]. Participants
who lacked data on BP (n¼ 6), BMI (n¼ 7), serum
lipids (n¼ 3), salt intake (n¼ 2) and level of educa-
tion (n¼ 14) were excluded, as well as participants
that used antihypertensive treatment at baseline
(n¼ 50), leaving 2,008 women and 1,610 men eligible
for the present analysis. For the analysis of incident
hypertension, 254 women and 441 men who had SBP
140mmHg and/or DBP 90mmHg at baseline,
were excluded. All participants provided written
informed consent. The present study was performed
according to the declaration of Helsinki, and the
study protocol was approved by the Regional
Committee for Medical and Health Research Ethics
(2017/294).
Blood pressure measurement
Heart rate, SBP and DBP were measured by trained
health workers after at least 2min of rest in the sit-
ting position using calibrated sphygmomanometers
(Dinamap 845 XT or Dinamap 8100, Criticon,
Tampa, FL) [10]. Brachial BP was measured at the
heart level on the right arm. The BP was measured in
triplets with one-minute intervals during staff attend-
ance, and the average of the two last measurements
was taken as the clinic BP and used for the analyses.
High-normal BP was defined as SBP 130–139mmHg
and/or DBP 85–89mmHg in accordance with
European guidelines [11]. Hypertension was defined
as BP 140/90mmHg. Incident hypertension was
defined as a reported use of antihypertensive medica-
tion or hypertension at the follow-up examination.
Other cardiovascular risk factors
Height and weight were measured without shoes,
height to the nearest centimeter, and weight with light
clothing to the nearest half-kilogram on a calibrated
scale. BMI was calculated as weight in kg/height2.
Overweight was defined as BMI 25.0–29.9 kg/m2 and
obesity as BMI 30.0 kg/m2 [12]. Information about
medical history, CV risk factors including smoking,
alcohol intake, use of extra table salt on food,
education, menopausal status, contraceptive pills, hor-
mone replacement therapy, antihypertensive medica-
tion and time since last meal was collected in self-
reported questionnaires at both surveys. Smoking was
defined as current daily smoking and education was
classified as (1) primary education/lower secondary
school, (2) upper secondary school and (3) higher
education. Non-fasting blood samples were analyzed
for serum triglycerides and total cholesterol.
Outcome
The following outcomes were assessed (1) change in
SBP during follow up, (2) change in DBP during fol-
low up and (3) incident hypertension, defined as
recorded BP 140mmHg systolic and/or 90mmHg
diastolic or reported use of antihypertensive medica-
tion at the follow-up examination.
Statistical analyses
Statistical analyses were done using STATA, version
15 (StataCorp LP, College Station, TX). Continuous
variables are expressed as means and standard devia-
tions (SD) or medians and interquartile ranges (IQR)
and categorical variables as numbers and percentages.
Comparisons between groups were done using the
Student’s t-test or the Chi-square test. For non-
normally distributed variables (serum triglycerides)
comparison between groups was done by quantile
regression. Factors associated with changes in SBP
and DBP from baseline to the follow-up survey were
identified in uni- and multivariable linear regression
analyses. Results are reported as standardized b-coef-
ficients and p-values. Factors associated with incident
hypertension were identified using uni- and multivari-
able logistic regression analyses. Results are presented
as odds ratios (OR), 95% confidence intervals (CI)
and p-values. Cubic spline plots with multivariable
adjustments were performed to visualize the associ-
ation between continuous independent variables and
changes in SBP or DBP. Non-linear associations
detected in cubic spline plots were further tested in a
linear spline plot. Linear spline plots with one knot
(the point at which the linear slope changed) and
multivariable adjustments were performed for the
association between baseline BMI and change in SBP
and DBP. The knot was placed based on a visual
assessment of the cubic spline plot. All multivariable
models were adjusted for baseline BP (SBP, DBP or
presence of high-normal BP, respectively), BMI and
education. Adjustment for time since last meal at
268 E. KRINGELAND ET AL.
baseline was done in models on serum triglycerides,
while adjustment for time since last meal at baseline
and follow-up was done in models on change in tri-
glycerides. Adjustment for change in BMI was done
in models on change in serum cholesterol and serum
triglycerides. Additional adjustment for baseline
serum cholesterol and triglycerides was done in mod-
els on change in serum cholesterol and triglycerides,
respectively. Separate analyses were performed for
women and men. Covariates of incident hypertension
were explored also in the total study population. To
test for interactions between explanatory variables and
sex in the total study population, we compared a
model with an interaction term with a model without
an interaction term using the likelihood-ratio test. A




At baseline, SBP and DBP were lower in women than
in men, and high-normal BP and hypertension were
both less prevalent in women (all p< 0.001) (Table
1). Compared to men, women also had a lower base-
line BMI, serum total cholesterol and triglycerides,
and lower prevalence of overweight (all p< 0.001)
(Table 1). Obesity was rare, found in 5.0% in women
and 5.2% in men (p¼ 0.81) (Table 1). Alcohol intake
was lower in women than in men 1.8 vs. 4.1 units per
week (p< 0.01). The use of contraceptive pills and
hormone replacement therapy was reported by 48
(2.5%) and 57 (2.8%) women, respectively. Only 1.1%
of women were postmenopausal at baseline.
When tested by the likelihood-ratio test we found
significant interactions between baseline SBP and
DPB with sex and changes in SBP and DBP, respect-
ively. Similarly, there were significant interactions
between quartiles of serum triglycerides and change
in serum cholesterol with sex in the model on inci-
dent hypertension.
Factors associated with BP development in
women during follow-up
On average women had a significant increase in SBP
and a decrease in average DBP during follow-up (all
p< 0.001) (Table 1). An increase in SBP and DBP
was seen in 54% and 30% of women, respectively.
Higher BMI was associated with a larger increase
in SBP both in uni- and multivariable linear
regression analysis (p< 0.001) (Table 2). A J-shaped
relationship between baseline BMI and change in
SBP was demonstrated in a cubic spline plot
(Figure 1a). Using linear spline plot, a positive asso-
ciation between baseline BMI and increase in SBP
was demonstrated in women with BMI >21 kg/m2
(b¼ 0.13, p< 0.001), while no significant association
between baseline BMI and change in SBP was
found in women with lower BMI (b ¼ 0.04,
p¼ 0.07). The baseline heart rate was positively
associated with a change in SBP in multivariable
linear regression analysis (p¼ 0.014) (Table 2).
During follow-up, larger increases in BMI, serum
cholesterol, and triglycerides were all associated with
a larger increase in SBP (all p< 0.001) (Table 2).
Adding the use of contraceptive pills and hormone
replacement therapy to the multivariable model did
not alter the positive association between increase
in serum triglycerides and increase in SBP in
women (b¼ 0.086, p< 0.001).
A J-shaped relationship was also found between
baseline BMI and change in DBP (Figure 1b). In lin-
ear spline plot, baseline BMI was associated with an
increase in DBP in women with BMI above 21 kg/m 2
(b¼ 0.060, p¼ 0.01), while no significant association
was found in those with lower baseline BMI.
Increases in BMI, serum cholesterol and triglycerides
during follow-up were all associated with an increase
in DBP (all p< 0.01) (Table 3) (Figure 2b). Adding
the use of contraceptive pills and hormone replace-
ment therapy to the multivariable model did not alter
the positive association between increase in serum tri-
glycerides and increase in DBP in women
(b¼ 0.071, 0.003).
Factors associated with BP development in men
during follow-up
On average both SBP and DBP decreased from base-
line to follow-up in men (both p< 0.001) (Table 1).
However, an increase in SBP and DBP was seen in 44
and 41% of men, respectively. Thus, an increase in
SBP was more common in women, while an increase
in DBP was more common in men (both p< 0.001
between sexes).
Higher BMI, heart rate and serum cholesterol at
baseline were identified as predictors of SBP
increase in men in multivariable linear regression
analyses (all p< 0.05) (Table 2). There was a close
to the linear relationship between baseline BMI and
change in SBP in men in the cubic spline plot
(Figure 1c). Furthermore, increases in BMI, serum
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cholesterol, and triglycerides in men during follow-
up were all associated with an increase in SBP (all
p< 0.01) (Table 2).
There was a close to the linear relationship
between baseline BMI and change in DBP in men
(Figure 1d). Higher baseline BMI and larger increases
Table 1. Characteristics of the study population at baseline and follow-up.
Variables








(n¼ 1,610) p Women Men p
Age, years 42 ± 1 42 ± 1 0.311 48 ± 1 48 ± 1 0.084 6.0 ± 1 6.0 ± 1 0.414
SBP, mmHg 122± 14 132 ± 13 <0.001 124 ± 16 130 ± 14 <0.001 1.8 ± 12 1.2 ± 11 <0.001
DBP, mmHg 75 ± 10 80 ± 9 <0.001 72 ± 11 78 ± 10 <0.001 3.7 ± 8 1.5 ± 8 <0.001
Hypertension, n (%) 254 (13) 441 (27) <0.001 300 (15) 391 (24) <0.001
High-normal BP, n (%) 319 (16) 446 (28) <0.001 330 (16) 411 (26) <0.001
Heart rate, beats per minute 75 ± 13 70 ± 13 <0.001
BMI, kg/m2 23.7 ± 3.4 25.1 ± 2.9 <0.001 24.8 ± 4.0 26.1 ± 3.2 <0.001 1.1 ± 1.7 1.0 ± 1.4 0.078
Overweight, n (%) 438 (22) 669 (42) <0.001 603 (30) 814 (51) <0.001
Obesity, n (%) 100 (5.0) 83 (5.2) 0.811 185 (9.2) 179 (11) 0.058
Serum cholesterol, mmol/L 5.4 ± 1.0 5.7 ± 1.0 <0.001 5.7 ± 1.0 5.8 ± 1.0 <0.001 0.3 ± 0.8 0.1 ± 0.8 <0.001





Mean time since last meal, hours 3.0 ± 1.8 3.1 ± 2.0 0.31 2.6 ± 1.7 2.8 ± 2.1 0.003
Extra table salt on food, n (%) 540 (27) 593 (37) <0.001
Alcohol intake, units/week 1.8 ± 2.7 4.1 ± 1.4 <0.001
Diabetes mellitus, n (%) 6 (0.3) 9 (0.6) 0.226 9 (0.5) 20 (1.2) 0.015
Daily smoker, n (%) 743(37) 604(37) 0.751 687 (34) 550 (34) 0.646
Cardiovascular disease, n (%) 4 (0.20) 2 (0.12) 0.58 5 (0.25) 18 (1.1) 0.001
Thyroid disease, n (%) 51 (3.0) 8 (0.59) <0.001
Kidney disease, n (%) 63 (3.1) 31 (1.93) 0.023
Education, n (%) <0.001
Primary/lower secondary school 534 (27) 290 (18)
Upper secondary school 862 (43) 674 (42)
Higher education 612 (30) 646 (40)
SBP: systolic blood pressure; DBP: diastolic blood pressure; BP: blood pressure; BMI: body mass index; Overweight: BMI 25.0–29.9 kg/m2; Obesity: BMI
30.0 kg/m2; Cardiovascular disease: self-reported stroke or myocardial infarction.
Data are given as median (IQR) for serum triglycerides, as mean ± SD for other continuous variables and as n (%) for categorical variables.p-Values for differences between women and men.
Table 2. Factors associated with change in systolic blood pressure over 6 years in midlife.
Variable
Women Men
Univariate Multivariable Univariate Multivariable
b p b p b p b p
Baseline
Baseline SBP, mmHg 0.273 <0.001 20.298 <0.001 0.353 <0.001 20.373 <0.001
Baseline BMI, kg/m2 0.052 0.021 0.109 <0.001 0.014 0.562 0.104 <0.001
Baseline heart rate beats/minute 0.035 0.120 0.055 0.014 0.0003 0.991 0.082 0.001
Serum cholesterol, mmol/L 0.027 0.232 0.014 0.537 0.017 0.508 0.049 0.040
Serum triglycerides, mmol/L 0.013 0.566 0.013a 0.582 0.010 0.675 0.022a 0.390
Smoking 0.003 0.909 0.007 0.739 0.007 0.784 0.007 0.782
Diabetes 0.024 0.290 0.017 0.430 0.014 0.566 0.019 0.410
Adding table salt on food 0.024 0.285 0.021 0.325 0.059 0.017 0.039 0.094
Education
Primary/lower secondary school (ref) (ref) (ref) (ref)
Upper secondary school 0.064 0.018 0.058 0.026 0.013 0.716 0.016 0.621
Higher education 0.010 0.712 0.018 0.498 0.055 0.110 0.023 0.482
Changes during follow-up
D BMI, kg/m2 0.208 <0.001 0.199 <0.001 0.172 <0.001 0.176 <0.001
D Serum cholesterol, mmol/L 0.116 <0.001 0.094a <0.001 0.094 <0.001 0.106a <0.001
D Serum triglycerides, mmol/L 0.114 <0.001 0.084a <0.001 0.095 <0.001 0.090a 0.001
SBP: systolic blood pressure; BMI: body mass index.
b: coefficients for factors significantly associated with increase in SBP in multivariable analysis are written in bold.
Distinct multivariable models were built for each explanatory variable. All multivariable models were adjusted for baseline systolic BP, education and
baseline BMI.
aAdjustment for time since last meal at baseline was done in models on serum triglycerides, while adjustment for time since last meal at baseline and
follow up was done in models on change in triglycerides. Adjustment for change in BMI was done in models on change in serum cholesterol and serum
triglycerides. Additional adjustment for baseline serum cholesterol or triglycerides was done in models on change in serum cholesterol or triglycerides,
respectively.
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in BMI, serum cholesterol and triglycerides during
follow-up were all positively associated with an
increase in DBP in men (all p< 0.01) (Table 3)
(Figure 2d).
Incident hypertension during follow-up
Among the 1754 women and 1169 men who were
normotensive at baseline, a lower proportion of
women than men developed incident hypertension
during 6 years follow-up (185 [11%] vs. 161 [14%],
respectively, p< 0.01). Among these, 51 (15%) sub-
jects were classified as having incident hypertension
based upon antihypertensive drug use alone. In a uni-
variate analysis in the total study population, women
were less prone to develop incident hypertension
compared to men (OR 0.74, 95% CI: 0.59–0.93,
p¼ 0.008). After multivariable adjustments for base-
line high-normal BP, BMI and education, women had
a comparable risk of incident hypertension to that
observed in men (OR 1.20, 95% CI: 0.93–1.52,
p¼ 0.17). If baseline high-normal BP was replaced by
baseline SBP in this model, women had a higher risk
of incident hypertension than men (OR 1.42, 95% CI:
1.11–1.82, p¼ 0.005).
Factors associated with incident hypertension
in women
In women, higher BMI and high-normal BP at base-
line predicted a higher incidence of hypertension
(Table 4). In addition, increases in BMI, serum chol-
esterol and triglycerides during follow-up, were all
associated with a higher risk for incident hypertension
in multivariable logistic regression analysis (all
p< 0.05) (Table 4). Women in the highest quartile of
serum triglycerides had a higher risk of incident
hypertension compared to women in the lowest quar-
tile (p¼ 0.016) (Table 4). Additional adjustment for
use of contraceptive pills and hormone replacement
therapy in the multivariable analyses did not alter the
association between having serum triglycerides in the
highest compared to the lowest quartile with incident
hypertension in women (OR 1.87, 95% CI: 1.14–3.10,
p¼ 0.014), nor the association between increase in
serum triglycerides and incident hypertension in
women (OR 1.30, 95% CI: 1.07–1.58, p¼ 0.009).
Factors associated with incident hypertension
in men
Also in men, higher BMI and high-normal BP at
baseline predicted incident hypertension at follow-up
(Table 4). In multivariable logistic regression analysis,
the presence of high-normal BP and higher BMI at
baseline, and larger increases in BMI and serum tri-
glycerides during follow-up, were all associated with a
higher risk of incident hypertension (all p< 0.05)
(Table 4). Having serum triglycerides in the highest
compared to the lowest quartile was not associated
with incident hypertension in men.
Discussion
It has been demonstrated that BP trajectories differ
between women and men [6]. While rates of increase
in SBP and DBP decline in men from 40 years and
onward, rates of SBP and DBP increase remain
Figure 1. (a–d) Change in SBP and DBP over 6 years associ-
ated with baseline BMI in women and men in their forties.
Median BMI at baseline is the reference point. The model is
adjusted for baseline blood pressure and education. BMI: body
mass index; SBP: systolic blood pressure; DBP: diastolic
blood pressure
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constant with increasing age in women [6]. The pre-
sent analysis from the Hordaland Health study aimed
at identifying factors associated with an increase in
BP and incident hypertension over 6 years in women
and men in their forties. We found that although BP
development significantly differed between women
and men in early midlife, higher BMI, weight gain
and increases in serum lipids were the main factors
associated with an increase in BP in both sexes. As
expected, a lower proportion of women than men
developed incident hypertension during 6 years fol-
low-up. However, after adjustments for baseline BP
category, BMI and education, the risk of incident
hypertension was similar in women and men. The
presence of high-normal BP at baseline was an
important predictor of incident hypertension in
both sexes.
Our sex-specific analysis expands previous results
from the population-based Framingham Heart Study
and Strong Heart Study that both were based upon
on average overweight subjects with a mean age of
around 50 years, and that did not present sex-specific
results [2,3]. In the Framingham Heart Study, the
presence of high-normal BP was associated with a 12-
fold higher risk of incident hypertension over 4 years
compared to those with optimal initial BP.
Furthermore, a 5% weight gain was associated with
an additional 20–30% increased risk of incident
hypertension during follow-up [2]. In a sub-study of
967 mostly obese North-American Indians with initial
optimal BP in the Strong Heart Study, higher SBP
and waist circumference at baseline and increases in
these factors were associated with incident hyperten-
sion after 8 years follow-up [3].
It is of particular interest that an association
between baseline BMI and increases in SBP and DBP
was evident in both sexes in our population that
mostly included non-obese subjects. Our results indi-
cate that level of BMI, even within the normal range
is associated with a change in BP in early midlife.
While a positive association between baseline BMI
and change in SBP and DBP was evident over the
whole BMI spectrum in men, the association between
baseline BMI and increase in BP was J-shaped in
women. The lowest increase in BP was seen in
women with a BMI of around 21 kg/m2. Previous
studies on the association of BMI with BP change
have reported diverging results [4,13,14]. In a study
by Liu K et al., including both black and white young
adults, similar associations between higher baseline
BMI and BMI increase with increases in SBP and
DBP were found in both sexes [15]. In contrast, in
the community-based Tromsø study, higher baseline
BMI was associated with larger increases in SBP and
DBP over 8 years in women than men in a population
with an initial mean age of 39 years [4]. However, in
the Tromsø study, adjustment for baseline BP was
not performed, although the initial SBP was
Table 3. Factors associated with change in diastolic blood pressure over 6 years in midlife.
Variable
Women Men
Univariate Multivariable Univariate Multivariable
b p b p b p b p
Baseline
Baseline DBP, mmHg 0.303 <0.001 20.308 <0.001 0.396 <0.001 20.411 <0.001
Baseline BMI, kg/m2 0.026 0.249 0.038 0.083 0.019 0.453 0.075 0.001
Baseline heart rate beats/minute 0.143 <0.001 0.030 0.197 0.136 <0.001 0.004 0.886
Serum cholesterol, mmol/L 0.097 <0.001 20.051 0.019 0.045 0.074 0.012 0.600
Triglycerides, mmol/L 0.045 0.043 0.006 a 0.807 0.046 0.062 0.005 a 0.843
Smoking 0.026 0.244 0.010 0.637 0.014 0.578 0.011 0.646
Diabetes 0.009 0.690 0.003 0.873 0.039 0.118 0.022 0.345
Adding table salt on food 0.037 0.097 0.032 0.133 0.032 0.201 0.027 0.240
Education
Primary/lower secondary school (ref) (ref) (ref) (ref)
Upper secondary school 0.028 0.312 0.021 0.421 0.006 0.869 0.005 0.869
Higher education 0.067 0.014 0.030 0.246 0.038 0.271 0.029 0.363
Changes during follow-up
D BMI, kg/m2 0.118 <0.001 0.125 <0.001 0.123 <0.001 0.138 <0.001
D Serum cholesterol, mmol/L 0.154 <0.001 0.119a <0.001 0.153 <0.001 0.136a <0.001
D Serum triglycerides, mmol/L 0.065 0.003 0.068a 0.004 0.049 0.050 0.067a 0.011
DBP: diastolic blood pressure; BMI: body mass index.
b: coefficients for factors significantly associated with increase in DBP in multivariable analysis are written in bold.
Distinct multivariable models were built for each explanatory variable. All multivariable models were adjusted for baseline DBP, education and base-
line BMI.
aAdjustment for time since last meal at baseline was done in models on serum triglycerides, while adjustment for time since last meal at baseline and
follow up was done in models on change in triglycerides. Adjustment for change in BMI was done in models on change in serum cholesterol and serum
triglycerides. Additional adjustment for baseline serum cholesterol or triglycerides was done in models on change in serum cholesterol or triglycerides,
respectively.
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10mmHg lower in women than in men. Also in a
Japanese cohort study including 6803 men and 22,800
women aged 40–79 years, incident hypertension was
more strongly associated with obesity in women than
in men [14].
Resting heart rate has been suggested as a marker
of sympathetic activity [16]. In a Chinese study,
higher resting heart rate was associated with a higher
risk of incident hypertension, however, separate anal-
yses in women and men were not presented [17]. In
the present sex-specific analysis, we found a positive
association between higher resting heart rate and
increase in SBP in women and men, but not with
incident hypertension.
Our results suggest a stronger association of ele-
vated serum triglycerides with incident hypertension
in women than in men. In contrast, elevated serum
triglycerides predicted development of hypertension
during 7 years follow-up in 311 Finnish men [18]. In
the Framingham offspring study, baseline BMI, serum
triglycerides, and increase in these factors were associ-
ated with an increase in mean BP over 6 years follow-
up, but sex-specific results were not reported [19].
The Copenhagen city study recently demonstrated a
positive association between higher levels of non-fast-
ing serum triglycerides and plasma C-reactive protein
(CRP) levels, suggesting that elevated serum triglycer-
ides is a marker of inflammation [20]. It has been
proposed that the presence of elevated serum trigly-
cerides may identify those at risk for diabetes devel-
opment [21,22]. Diabetes mellitus is a stronger risk
factor for coronary heart disease in women than men
[21,23]. Likewise, higher serum triglyceride levels
appear to be a more important risk factor for ischae-
mic heart disease in women than in men [21,23].
Because of the low prevalence of diabetes, we were
not able to test the association between diabetes and
incident hypertension in the present cohort.
We demonstrated an independent association of an
increase in serum cholesterol during follow-up with
increases in SBP and DPB in both sexes, and with
incident hypertension particularly in women. These
findings are in line with results in the Women’s
Health Study [24]. Furthermore, similar findings were
reported for men in the Physicians’ Health Study and
a Japanese cohort study of 14,215 male workers
[25,26]. Despite these findings, a meta-analysis of 18
randomized clinical trials assessing the effect of chol-
esterol-lowering treatment on BP reduction found no
evidence of substantial BP-lowering effect of statin
treatment [27].
Some study limitations should be outlined. The
Hordaland Health Study was performed in a small
region in Western Norway in an ethnically homogen-
ous study sample with a very low prevalence of obes-
ity. Thus, our results add to previous observations in
overweight and obese cohorts. However, the general-
isation of results should be done with caution. The
relatively large study sample and prospective design
are major strengths of this study. Furthermore, par-
ticipation rates were high, above 70% both at the
baseline and the follow-up survey [9]. Out of office
BP measurements were not included in the
Hordaland Health Study. Although only 51 (15%)
study participants were classified as having incident
hypertension at follow-up based solely on
Figure 2. (a–d) Change in SBP and DBP over 6 years in midlife
associated with change in BMI in women and men in their
forties. Median change in BMI is the reference point. The
model is adjusted for baseline blood pressure, BMI and educa-
tion. BMI: body mass index; SBP: systolic blood pressure; DBP:
diastolic blood pressure
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antihypertensive drug use, we cannot exclude that
some of these participants may have had another
indication for use of these drugs, and therefore were
misclassified. Information on the use of steroid hor-
mones and statin treatment was not included in the
baseline survey in 1992–1993. Serum triglycerides
were measured in non-fasting blood samples. Non-
fasting serum triglycerides probably have an even
stronger association with CVD than fasting triglycer-
ides level [28,29]. Finally, serum glucose, creatinine,
and thyroid hormones were not measured at baseline
in the present cohort. Medical history was collected
in self-reported questionnaires. Prevalent diabetes,
CVD, thyroid, and kidney disease may therefore be
underreported.
Conclusion
In the Hordaland Health Study, BP development dif-
fered between women and men in early midlife.
Higher BMI, weight gain, and increases in serum lip-
ids were the main factors associated with increases in
SBP and DBP and incident hypertension during
6 years follow-up both in women and men in their
forties. As initial blood pressure was lower in women
than in men, women were less prone to develop
hypertension during follow-up. The presence of high-
normal BP at baseline was an important predictor of
incident hypertension in both sexes.
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